Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Motor Activity 236 Breast Neoplasms 128 Neoplasms 103 Prostatic Neoplasms 35 Fatigue 34 Obesity 24 Lung Neoplasms 23 Colorectal Neoplasms 22 Polycystic Ovary Syndrome 17 Colonic Neoplasms 16 Ovarian Neoplasms 13 Precursor Cell Lymphoblastic Leukemia-Lymphoma 12 Pancreatic Neoplasms 11 Lymphoma 11 Carcinoma, Non-Small-Cell Lung 11 Weight Loss 10 Rectal Neoplasms 10 Multiple Myeloma 10 Lymphedema 10 Hematologic Neoplasms 10 Head and Neck Neoplasms 10 Leukemia 9 Insulin Resistance 8 Cardiotoxicity 8 Stomach Neoplasms 7 Peripheral Nervous System Diseases 6 Cognitive Dysfunction 6 Cachexia 6 Brain Neoplasms 6 Overweight 5

Interventions

sotrovimab 1 ciclesonide 1 Standard of Care 1 Procalcitonin 1 Practice Guidelines as Topic 1 Nivolumab 1 Niclosamide 1 Methods 1 Interviews as Topic 1 Immune Checkpoint Inhibitors 1 High-Intensity Interval Training 1 Exercise 1 Educational Status 1 Early Intervention, Educational 1 Cholecalciferol 1 Bortezomib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Lupus Erythematosus, Systemic × Exercise × Clear all

NCT05478018 2025-09-09

LUPEX

Rigshospitalet, Denmark

Phase NA Completed

Lupus Erythematosus, Systemic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡